The genetic background difference between diabetic patients with and without nephropathy in a taiwanese population by linkage disequilibrium mapping using 382 autosomal STR markers

Genetic Testing and Molecular Biomarkers

Volumn 14, Issue 3, 2010, Pages 433-438

  Pei, Dee ^a   Huang, Yi Jen ^b   Hsieh, Chang Hsun ^b   Kuo, Shi Wen ^c   Liou, Ya Huei ^d   Wu, Lawrence Shih Hsin ^e  

^a CARDINAL TIEN HOSPITAL   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^d VITA GENOMICS INC   (Taiwan)

^e TZU CHI UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; ANKS1B PROTEIN, HUMAN; CARRIER PROTEIN; MICROSATELLITE DNA;

ADULT; ARTICLE; ASIAN; AUTOSOMAL INHERITANCE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; EB 1 GENE; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENETIC MARKER; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION GENETICS; PRE B LYMPHOCYTE; SHORT TANDEM REPEAT; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHROMOSOME MAP; DIABETES MELLITUS; FEMALE; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PROCEDURES;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARRIER PROTEINS; CHROMOSOME MAPPING; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TAIWAN;

EID: 77954915689     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2009.0179     Document Type: Article

References (20)

1. Bird TD, Jarvik GP, Wood NW (2001) Genetic association studies: genes in search of diseases. Neurology 57:1153-1154.
2. Caramori ML, Canani LH, Costa LA, Gross JL (2003) The human peroxisome proliferator-activated receptor gamma2 (PPAR-gamma2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes. Diabetes 52:3010-3013.
3. Conway BR, Maxwell AP (2009) Genetics of diabetic nephrop-athy: are there clues to the understanding of common kidney diseases? Nephron Clin Pract 112:c213-c221.
4. Excerpts from the United States Renal Data System (2001) Annual Data Report: Atlas of end-stage renal diseases in the United States. Am J Kidney Dis 38 (Suppl. 3):S1-S176.
5. Imperatore G, Hanson RI, Pettitt DJ, et al. (1998) Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Diabetes 47:821-830.
6. Jacobsen P, Tarnow L, Carstensen B, et al. (2003) Genetic variation in the renin-angiotensin system and progression of diabetic nephropathy. J Am Soc Nephrol 14:2843-2850.
7. Krolewski AS, Waram JH, Rand LI, Kahn CR (1987) Epidemio-logic approach to the etiology of type I diabetes mellitus and its complications. N Engl J Med 317:1390-1398.
8. 2 receptor gene polymorphism in associated with altered urinary albumin/creatinine value in diabetic patients. Can J Physiol Pharmacol 80:323-327.
9. Moczulski DK, Rogus JJ, antonellis A, et al. (1998) Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q. Diabetes 47:1164-1169.
10. Nakajima K, Tanaka Y, Nomiyama T, et al. (2003) RANTES promoter genotype is associated with diabetic nephropathy in type 2 diabetic subjects. Diabetes Care 26:892-898.
11. Neugebauer S, Baba T, Watanabe T (2000) Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes. Diabetes 49:500-503.
12. Patient registration committee (2002) Japanese society for dialysis therapy: the current state of chronic dialysis treatment in Japan. J Jpn Soc Dial Ther 35:1155-1184.
13. Quinn M, Angelico MC, Warram JH, Krolewski AS (1996) Familial factors determine the development of diabetic ne-phropathy in patients with IDDM. Diabetologia 39:940-945.
14. Rychlik I, Miltenberger-Miltenyi G, Ritz E (1998) The drama of the continuous increase in end-stage renal failure in patients with type II diabetes mellitus. Nephrol Dial Transplant 13:6-10.
15. Sham PC, Curtis D (1995) Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 59:97-105.
16. Sun J, Xu Y, Zhu Y, Lu H (2004) Genetic polymorphism of me-thylenetetrahydrofolate reductase as a risk factor for diabetic nephropathy in Chinese type 2 diabetic patients. Diabetes Res Clin Pract 64:185-190.
17. Tanaka N, Babazono T, Saito S, et al. (2003) Association of solute carrier family 12 (sodium/chloride) member 3 with diabetic nephropathy, identified by genome-wide analyses of single nucleotide polymorphisms. Diabetes 52:2848-2853.
18. Vardarli I, Baier LJ, Hanson RL, et al. (2002) Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q22.3-23. Kidney Int 62:2176-2183.
19. Wang JY, Lin CGJ, Bey MSJ, et al. (2005) Discovery of genetic difference between asthmatic children with high IgE level and normal IgE level by whole genome linkage disequilibrium mapping using 763 autosomal STR markers. J Hum Genet 50:249-258.
20. Zychma MJ, Gumprecht J, Zukowska-SzczechowskaE, etal. (1999) Polymorphismsinthe genes encodingfor human kinin receptors and the risk of end-stage renal failure: results of transmission/disequilibrium test. J Am Soc Nephrol 10:2120-2124.